Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
WCN26-5615 A 6-week treatment with semaglutide improves both kidney dysfunction and heart failure with preserved ejection fraction in the SDT fatty rat model

Francois Briand, Guillaume Bourdier, Estelle Grasset, Rana Assaly, Caroline Dubroca, Masami Shinohara, Thierry Sulpice. Kidney International Reports, Volume 11, Issue 4, Supplement, 2026, 104481, ISSN 2468-0249. doi.org/10.1016/j.ekir.2026.104481.